GoKawiilEli Lilly to Acquire Merida Biosciences for Up to $2.875 Billion
Eli Lilly has struck a cash deal worth as much as $2.875 billion to acquire Merida Biosciences, a biotechnology company. The acquisition is aimed at strengthening Lilly's immunology drug pipeline.